Cutting-Edge Research in Percutaneous Coronary Intervention

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (14 December 2023) | Viewed by 920

Special Issue Editor


E-Mail Website
Guest Editor
Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Interests: coronary artery disease; intravascular imaging; structural heart disease; transcatheter aortic valve replacement; left atrial appendage closure

Special Issue Information

Dear Colleagues,

As you all know, coronary artery disease (CAD) is a global health problem. Not only is it problematic for individuals in terms of suffering and impaired quality of life but is also a life-threatening situation once it becomes unstable. CAD is also problematic for society in terms of costs for healthcare, sickness benefits, and lost productivity. There are many recent large randomized clinical trials addressing CAD, from questioning the benefits of its treatment to new information regarding its benefits not only for reduction in mortality and impact on life expectancy, but especially for improvement in the quality of life of patients.

The purpose of this Special Issue is to discuss the current assessment for CAD, including new data and new technical approaches and technologies. With the improvement of intravascular imaging, new atherectomy options, and new devices, the focus of this issue will be on non-pharmacological approaches. The scope of the issue is deliberately broad to encourage coverage of a wide range of topics and perspectives related to the management of CAD.

Dr. Luís Augusto Palma Dallan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease (CAD)
  • percutaneous coronary intervention (PCI)
  • angina
  • myocardial infarct
  • atherectomy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 7898 KiB  
Review
In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management
by Neda Shafiabadi Hassani, Lucas Carlini Ogliari, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Marcelo Harada Ribeiro and Luis Augusto Palma Dallan
Medicina 2024, 60(4), 549; https://doi.org/10.3390/medicina60040549 - 28 Mar 2024
Viewed by 699
Abstract
Despite ongoing progress in stent technology and deployment techniques, in-stent restenosis (ISR) still remains a major issue following percutaneous coronary intervention (PCI) and accounts for 10.6% of all interventions in the United States. With the continuous rise in ISR risk factors such as [...] Read more.
Despite ongoing progress in stent technology and deployment techniques, in-stent restenosis (ISR) still remains a major issue following percutaneous coronary intervention (PCI) and accounts for 10.6% of all interventions in the United States. With the continuous rise in ISR risk factors such as obesity and diabetes, along with an increase in the treatment of complex lesions with high-risk percutaneous coronary intervention (CHIP), a substantial growth in ISR burden is expected. This review aims to provide insight into the mechanisms, classification, and management of ISR, with a focus on exploring innovative approaches to tackle this complication comprehensively, along with a special section addressing the approach to complex calcified lesions. Full article
(This article belongs to the Special Issue Cutting-Edge Research in Percutaneous Coronary Intervention)
Show Figures

Figure 1

Back to TopTop